Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schulze-Koops

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Der Internist|June 12, 2016
[Hyperuricemia and gout : New aspects of an old disease]M Witt, H Schulze-Koops
Best Practice & Research. Clinical Rheumatology|January 29, 2002
The balance of Th1/Th2 cytokines in rheumatoid arthritisH Schulze-Koops, J R Kalden
Arthritis Research|November 30, 2000
Where is biological therapy going?H Schulze-Koops, J R Kalden
Deutsche Medizinische Wochenschrift (1946)|August 12, 2011
[Rheumatology today - a dynamic discipline for the patients' good]H Schulze-Koops, H E Blum
Current Directions in Autoimmunity|January 17, 2002
Anti-CD4 monoclonal antibody therapy in human autoimmune diseasesH Schulze-Koops, P E Lipsky
Zeitschrift Fur Rheumatologie|May 19, 2009
[Th17 cells - a new proinflammatory T cell population and its role in rheumatologic autoimmune diseases]J Leipe, A Skapenko, H Schulze-Koops
Zeitschrift Fur Rheumatologie|July 10, 2012
[Th9 cells. Functionally important or just an epiphenomenon?]A Ramming, H Schulze-Koops, A Skapenko
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
What we have learned from trials of immunomodulatory agents in rheumatoid arthritis: Future directionsH Schulze-Koops, H Burkhardt, J R Kalden
Scandinavian Journal of Rheumatology|December 1, 2001
Treatment of rheumatoid arthritis in the third millenniumA Skapenko, J R Kalden, H Schulze-Koops
Clinical and Experimental Rheumatology|November 21, 2007
The central role of T cells in rheumatoid arthritisA P Cope, H Schulze-Koops, M Aringer
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Der Internist|June 12, 2016
[Hyperuricemia and gout : New aspects of an old disease]M Witt, H Schulze-Koops
Best Practice & Research. Clinical Rheumatology|January 29, 2002
The balance of Th1/Th2 cytokines in rheumatoid arthritisH Schulze-Koops, J R Kalden
Arthritis Research|November 30, 2000
Where is biological therapy going?H Schulze-Koops, J R Kalden
Deutsche Medizinische Wochenschrift (1946)|August 12, 2011
[Rheumatology today - a dynamic discipline for the patients' good]H Schulze-Koops, H E Blum
Current Directions in Autoimmunity|January 17, 2002
Anti-CD4 monoclonal antibody therapy in human autoimmune diseasesH Schulze-Koops, P E Lipsky
Zeitschrift Fur Rheumatologie|May 19, 2009
[Th17 cells - a new proinflammatory T cell population and its role in rheumatologic autoimmune diseases]J Leipe, A Skapenko, H Schulze-Koops
Zeitschrift Fur Rheumatologie|July 10, 2012
[Th9 cells. Functionally important or just an epiphenomenon?]A Ramming, H Schulze-Koops, A Skapenko
Drugs of Today (Barcelona, Spain : 1998)|September 16, 2003
What we have learned from trials of immunomodulatory agents in rheumatoid arthritis: Future directionsH Schulze-Koops, H Burkhardt, J R Kalden
Scandinavian Journal of Rheumatology|December 1, 2001
Treatment of rheumatoid arthritis in the third millenniumA Skapenko, J R Kalden, H Schulze-Koops
Clinical and Experimental Rheumatology|November 21, 2007
The central role of T cells in rheumatoid arthritisA P Cope, H Schulze-Koops, M Aringer
Pageof 11